Gamco Investors INC. ET AL Purchases Shares of 25,900 Grail, Inc. (NASDAQ:GRAL)

Gamco Investors INC. ET AL purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 25,900 shares of the company's stock, valued at approximately $462,000. Gamco Investors INC. ET AL owned about 0.08% of Grail at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. FNY Investment Advisers LLC acquired a new position in shares of Grail during the fourth quarter worth about $26,000. Lindbrook Capital LLC acquired a new stake in shares of Grail in the 4th quarter valued at $28,000. Sterling Capital Management LLC purchased a new stake in shares of Grail during the 4th quarter worth $29,000. Wellington Shields Capital Management LLC purchased a new position in Grail in the fourth quarter valued at $33,000. Finally, New York State Common Retirement Fund acquired a new stake in Grail in the fourth quarter valued at $59,000.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Morgan Stanley boosted their price objective on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th. Canaccord Genuity Group began coverage on shares of Grail in a research note on Monday. They set a "buy" rating and a $32.00 price target for the company.

Insider Activity at Grail

In other Grail news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now owns 335,170 shares of the company's stock, valued at $10,457,304. This trade represents a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of the firm's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now owns 559,673 shares of the company's stock, valued at $17,461,797.60. This represents a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 11,550 shares of company stock worth $360,436.

Grail Stock Performance

NASDAQ:GRAL traded down $0.27 during mid-day trading on Friday, hitting $37.42. 433,298 shares of the company's stock traded hands, compared to its average volume of 1,220,974. The firm's 50 day simple moving average is $31.34 and its 200 day simple moving average is $24.09. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. As a group, research analysts expect that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.